Literature DB >> 9508330

Comparison of two enzyme-linked immunosorbent assays and one rapid immunoblot assay for detection of herpes simplex virus type 2-specific antibodies in serum.

J Groen1, G Van Dijk, H G Niesters, W I Van Der Meijden, A D Osterhaus.   

Abstract

The sensitivities and specificities of three immunoassays for the detection of herpes simplex virus type 2 (HSV-2)-specific immunoglobulin G antibodies in serum, including the one-strip rapid immunoblot assay (RIBA; Chiron Corporation) and two indirect enzyme immunosorbent assays (EIA; Gull Laboratories and Centocor), were compared by testing a panel of 1,250 serum samples from individuals attending an outpatient clinic for sexually transmitted diseases. A qualitative agreement among the three assays was observed with 1,080 serum samples (86.4%); 291 of the serum samples (23.3%) were positive, 789 samples (63.1%) were negative, and 170 serum samples (13.6%) gave a discordant result. Results were considered conclusive when a concordant result was obtained with two of three assays. The sensitivities and specificities of the RIBA, the Gull EIA, and the Centocor EIA proved to be 99.2, 99.7, and 89.9% and 97.1, 96.7, and 99.3%, respectively. These results indicate that the Chiron RIBA and the Gull EIA are especially useful and reliable for the detection of HSV-2-specific antibodies in serum.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9508330      PMCID: PMC104643          DOI: 10.1128/JCM.36.3.845-847.1998

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  8 in total

1.  Use of densitometric analysis for interpreting HSV serologies based on Western blot.

Authors:  R L Ashley; J Militoni
Journal:  J Virol Methods       Date:  1987-11       Impact factor: 2.014

Review 2.  Genital herpes and the pregnant woman.

Authors:  C G Prober; A M Arvin
Journal:  Curr Clin Top Infect Dis       Date:  1989

3.  Typing of clinical herpes simplex virus isolates with mouse monoclonal antibodies to herpes simplex virus types 1 and 2: comparison with type-specific rabbit antisera and restriction endonuclease analysis of viral DNA.

Authors:  E Peterson; O W Schmidt; L C Goldstein; R C Nowinski; L Corey
Journal:  J Clin Microbiol       Date:  1983-01       Impact factor: 5.948

4.  A novel glycoprotein for detection of herpes simplex virus type 1-specific antibodies.

Authors:  F K Lee; L Pereira; C Griffin; E Reid; A Nahmias
Journal:  J Virol Methods       Date:  1986-09       Impact factor: 2.014

5.  Herpes simplex virus type-selective enzyme-linked immunosorbent assay with Helix pomatia lectin-purified antigens.

Authors:  B Svennerholm; S Olofsson; S Jeansson; A Vahlne; E Lycke
Journal:  J Clin Microbiol       Date:  1984-02       Impact factor: 5.948

6.  Seroreactive recombinant herpes simplex virus type 2-specific glycoprotein G.

Authors:  D L Parkes; C M Smith; J M Rose; J Brandis; S R Coates
Journal:  J Clin Microbiol       Date:  1991-04       Impact factor: 5.948

7.  Encephalitis in immunocompetent patients due to herpes simplex virus type 1 or 2 as determined by type-specific polymerase chain reaction and antibody assays of cerebrospinal fluid.

Authors:  E Aurelius; B Johansson; B Sköldenberg; M Forsgren
Journal:  J Med Virol       Date:  1993-03       Impact factor: 2.327

8.  Indirect ELISA for the detection of HSV-2 specific IgG and IgM antibodies with glycoprotein G (gG-2).

Authors:  D W Ho; P R Field; E Sjögren-Jansson; S Jeansson; A L Cunningham
Journal:  J Virol Methods       Date:  1992-03       Impact factor: 2.014

  8 in total
  12 in total

1.  Evaluation of an enzyme immunoassay system for measuring herpes simplex virus (HSV) type 1-specific and HSV type 2-specific IgG antibodies.

Authors:  H E Prince; C E Ernst; W R Hogrefe
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

2.  Novel approach for specific detection of herpes simplex virus type 1 and 2 antibodies and immunoglobulin G and M antibodies.

Authors:  B Ohana; M Lipson; N Vered; I Srugo; M Ahdut; A Morag
Journal:  Clin Diagn Lab Immunol       Date:  2000-11

Review 3.  Sorting out the new HSV type specific antibody tests.

Authors:  R L Ashley
Journal:  Sex Transm Infect       Date:  2001-08       Impact factor: 3.519

4.  Herpes diagnostic tests and their use.

Authors:  Nicholas J Van Wagoner; Edward W Hook
Journal:  Curr Infect Dis Rep       Date:  2012-04       Impact factor: 3.725

5.  Evaluation of confirmatory strategies for detection of type-specific antibodies against herpes simplex virus type 2.

Authors:  Bodo Rolf Eing; Lars Lippelt; Eva Ulla Lorentzen; Wali Hafezi; Wolfgang Schlumberger; Katja Steinhagen; Joachim Ewald Kühn
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

6.  Serological evaluation of herpes simplex virus type 1 and type 2 infections in pregnancy.

Authors:  M Arvaja; M Lehtinen; P Koskela; M Lappalainen; J Paavonen; T Vesikari
Journal:  Sex Transm Infect       Date:  1999-06       Impact factor: 3.519

7.  Comparison of a monoclonal antibody-blocking enzyme-linked immunoassay and a strip immunoblot assay for identifying type-specific herpes simplex virus type 2 serological responses.

Authors:  G J Van Doornum; M J Slomka; M Buimer; J Groen; J A Van den Hoek; I Cairo; A Vyse; D W Brown
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

8.  Genital herpes serotesting: a study of the epidemiology and patients' knowledge and attitude among STD clinic attenders in Coventry, UK.

Authors:  N Narouz; P S Allan; A H Wade; S Wagstaffe
Journal:  Sex Transm Infect       Date:  2003-02       Impact factor: 3.519

9.  Use of a fragment of glycoprotein G-2 produced in the baculovirus expression system for detecting herpes simplex virus type 2-specific antibodies.

Authors:  Minako Ikoma; Jan-Ake Liljeqvist; Jan Groen; Koen L Glazenburg; T Hauw The; Sytske Welling-Wester
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

10.  Comparative performance of the Uni-Gold™ HSV-2 Rapid: a point-of-care HSV-2 diagnostic test in unselected sera from a reference laboratory.

Authors:  Enda Shevlin; Rhoda Ashley Morrow
Journal:  J Clin Virol       Date:  2014-08-27       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.